10 Movies That Prove 2023 Was the Heaviest Year in Cinema History

2023 saw a particularly high number of heavy movies getting released, including the likes of Oppenheimer, The Zone of ...
Barchart on MSN

Stocks retreat as bond yields rise

The S&P 500 Index ($SPX) (SPY) on Monday closed down by -0.35%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down by ...
Investing

Engene stock price target raised to $33 by Oppenheimer on strong trial data

Oppenheimer noted that the trial results address market skepticism that emerged following initial data released last September, prior to changes that aligned the trial design more closely with current ...

Looking at the Narrative for Roche After New Trial Results and Strategic Shifts

Roche Holding’s fair value estimate has edged up to about CHF 312 from roughly CHF 305, supported by a slightly higher long ...
Veritasium on MSN

This Is How Oppenheimer Unlocked a Force Strong Enough to End Civilizations

J. Robert Oppenheimer didn’t just lead a scientific breakthrough he altered the direction of human history. By unlocking the ...

Vicore to Present at the Oppenheimer Movers in Rare Disease Summit

STOCKHOLM, SE / ACCESS Newswire / December 5, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), ...

Capricor Therapeutics Shares Climb as Analysts Project Profitability by 2028

Capricor Therapeutics shares gained after analysts said they believe the company can achieve profitability by 2028. The stock rose 8.4% to $29.14 and hit its 52-week high of $14.87 earlier in the ...

Capricor: Maintaining 'Hold' Rating On Randomized Phase 3 HOPE-3 Trial Win With Deramiocel

Capricor shows positive HOPE-3 results with endpoints met, regulatory uncertainty, and a strong cash runway into 2026. Find ...
The Virgin Islands Consortium

$17,730 Lease Payment, “Everything Is Traceable,” and ‘Burn the Phone’: Prosecutors Deepen Case Against Martinez and O’Neal

Federal prosecutors used the third day of trial in the U.S. v. Ray Martinez and Jenifer O’Neal case to tighten their ...

Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit

Please contact your Oppenheimer representative to register for the Movers in Rare Disease Summit and to schedule a 1x1 meeting with Dr. Mor and Chemomab management.

FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit

SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the Oppenheimer Movers in Rare Disease Summit being ...